2025 annual financial data
RenovoRx 2025 Net margin
RenovoRx 2025 net margin with verified reported values.
Direct answer
Net margin was -994.48%.
Operating income was -12,510,000 USD and net income was -11,168,000 USD.
Operating cash flow was -10,973,000 USD.
Get free RenovoRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,123,000 USD
- Operating income
- -12,510,000 USD
- Net income
- -11,168,000 USD
- Operating cash flow
- -10,973,000 USD